Phase II study of nedaplatin and irinotecan in patients with extensive small-cell lung cancer

2013

Background The standard chemotherapy for Japanese patients with extensive disease of small-cell lung cancer (ED-SCLC) is cisplatin and irinotecan.

Keywords:

Correction
Source
Cite
Save
Machine Reading By IdeaReader

21

References

4

Citations